Publications by authors named "B Hatami"
Lifestyle and Pharmacologic Approaches to Prevention of MASLD-related HCC.
Clin Gastroenterol Hepatol
January 2025
Hepatocellular carcinoma (HCC) is a major concern for public health. Fatty liver disease, related to alcohol misuse or metabolic syndrome, has become the leading cause of chronic liver disease and HCC. The strong association between type 2 diabetes mellitus and HCC can be partly attributed to the development of metabolic dysfunction associated steatotic liver disease (MASLD).
View Article and Find Full Text PDFAim: We investigated the possibility of caffeine supplementation for managing the inflammation, and hepatic function in cirrhotic patients.
Methods: In this randomized, double-blind, placebo-controlled trial, fifty patients with cirrhosis were randomly assigned to receive either caffeine supplement (400 mg), or placebo for eight weeks.
Results: The results indicated a significant decrease in AST, platelets (P = 0.
Background: Following a plant-based diet is associated with a wide range of health benefits. The current study aimed to investigate the association between plant-based diet indices, specifically the plant-based diet index (PDI), healthful PDI (hPDI), and unhealthful PDI (uPDI) and risk of mortality in cirrhotic patients.
Methods: This cohort study included a total of 121 patients with cirrhosis, who were followed for four years.
Liver Cirrhosis, defined as the final stage of chronic liver disease, may become more prevalent in the lower level of body defense against oxidation and inflammation. Therefore, we assessed the association of dietary total antioxidant capacity (DTAC) with the severity and mortality of cirrhosis in a cohort study. 120 newly diagnosed cirrhosis patients from Tehran, Iran, participated in this study.
View Article and Find Full Text PDFArticle Synopsis
- Portal vein thrombosis (PVT) is a serious condition that can happen in people with liver disease called cirrhosis, which can cause bleeding and issues during liver transplants.
- A study looked at 928 cirrhotic patients to see what factors might increase their risk of developing PVT, finding links to Hepatitis B, liver cancer, and certain symptoms like swollen belly and infections.
- The results showed that older patients and those with higher MELD scores (which measure how badly the liver is damaged) are more likely to have PVT, suggesting doctors can help by keeping a close eye on these patients.